Namrata Sethi

6PUBLICATIONS
15CO-AUTHORS
Molecular targetsPredictive and prognostic markersPacific Peoples cultural determinants of healthEthical use of new technology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 27, 2025
Preclinical Efficacy of the Estrogen Receptor Degrader Fulvestrant in Combination with RAF/MEK Clamp Avutometinib and FAK Inhibitor in a Low-Grade Serous Ovarian Cancer Animal Model with Acquired Resistance to Chemotherapy and Aromatase Inhibitor.

Cem Demirkiran, Stefania Bellone, Victoria M Ettorre

|Aug 27, 2025
Preclinical Activity of Datopotamab Deruxtecan (Dato-DXd), an Antibody-Drug Conjugate Targeting TROP2, in Poorly Differentiated Endometrial Carcinomas.

Niccolò G Santin, Namrata Sethi, Stefania Bellone

|Jun 13, 2025
Personalized Treatment in Ovarian Cancer: A Review of Disease Monitoring, Biomarker Expression, and Targeted Treatments for Advanced, Recurrent Ovarian Cancers.

Victoria M Ettorre, Abdelrahman AlAshqar, Namrata Sethi

|Apr 29, 2025
Preclinical Activity of Datopotamab Deruxtecan, an Antibody-Drug Conjugate Targeting Trophoblast Cell-Surface Antigen 2, in Uterine Serous Carcinoma.

Michelle Greenman, Cem Demirkiran, Stefania Bellone

|Apr 26, 2025
Updates in Pessary Care for Pelvic Organ Prolapse: A Narrative Review.

Namrata Sethi, Ghanshyam S Yadav

|Nov 21, 2024
What Patients Think About Robot-Assisted Surgery: Lessons to Learn from the Awareness and Perception Study in Mumbai.

Anshumala Shukla-Kulkarni, Namrata Sethi

Pageof 1

Frequent Collaborators

4 joint publications

Victoria M Ettorre

4 joint publications

Alessandro D Santin

3 joint publications

Cem Demirkiran

3 joint publications

Stefania Bellone